Ironwood Pharmaceuticals Inc (IRWD)
3.44
+0.10
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
3.42
-0.02
(-0.58%)
After-Hours: 20:00
Ironwood Pharmaceuticals Total Liabilities (Quarterly): 700.85M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 700.85M |
| June 30, 2024 | 717.35M |
| March 31, 2024 | 769.34M |
| December 31, 2023 | 817.37M |
| September 30, 2023 | 849.74M |
| June 30, 2023 | 950.00M |
| March 31, 2023 | 448.42M |
| December 31, 2022 | 448.14M |
| September 30, 2022 | 449.28M |
| June 30, 2022 | 442.81M |
| March 31, 2022 | 565.60M |
| December 31, 2021 | 521.02M |
| September 30, 2021 | 499.43M |
| June 30, 2021 | 495.46M |
| March 31, 2021 | 489.15M |
| December 31, 2020 | 496.60M |
| September 30, 2020 | 486.42M |
| June 30, 2020 | 480.39M |
| March 31, 2020 | 475.56M |
| December 31, 2019 | 496.00M |
| September 30, 2019 | 487.39M |
| June 30, 2019 | 535.09M |
| March 31, 2019 | 600.72M |
| December 31, 2018 | 528.42M |
| September 30, 2018 | 613.95M |
| Date | Value |
|---|---|
| June 30, 2018 | 662.17M |
| March 31, 2018 | 589.15M |
| December 31, 2017 | 595.83M |
| September 30, 2017 | 642.66M |
| June 30, 2017 | 700.21M |
| March 31, 2017 | 671.68M |
| December 31, 2016 | 643.10M |
| September 30, 2016 | 672.52M |
| June 30, 2016 | 618.83M |
| March 31, 2016 | 512.39M |
| December 31, 2015 | 524.00M |
| September 30, 2015 | 512.97M |
| June 30, 2015 | 513.66M |
| March 31, 2015 | 237.37M |
| December 31, 2014 | 240.77M |
| September 30, 2014 | 238.02M |
| June 30, 2014 | 229.23M |
| March 31, 2014 | 229.93M |
| December 31, 2013 | 240.74M |
| September 30, 2013 | 241.63M |
| June 30, 2013 | 244.62M |
| March 31, 2013 | 266.57M |
| December 31, 2012 | 85.86M |
| September 30, 2012 | 64.41M |
| June 30, 2012 | 79.88M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
442.81M
Minimum
Jun 2022
950.00M
Maximum
Jun 2023
579.95M
Average
496.30M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
| Oragenics Inc | 2.126M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 389.52M |
| Shareholders Equity (Quarterly) | -311.33M |
| Debt to Equity Ratio | -1.923 |
| Current Ratio | 3.617 |
| Net Debt Paydown Yield | 6.01% |